Home > 受賞・論文発表
教育・研究
業績 業績
Performance

受賞・論文発表

2024年

論文発表

  1. Hara S, Sakai D, Ikemura K, Shintani T, Yamamoto T, Satoh T, Okuda M.
    Comparative efficacy and safety of standard and biweekly trifluridine/tipiracil regimen in patients with colorectal cancer.
    Anticancer Res. 44: 1219-1226 (2024) DOI:10.21873/anticanres.16917
  2. Shimamoto Y, Fukushima K, Mizuno T, Ichikawa H, Kurosaki K, Maeda S, Okuda M.
    Model-informed vancomycin dosing optimization to address delayed renal maturation in infants and young children with critical congenital heart disease.
    Clin Pharmacol Ther. 115(2):239-247 (2024) DOI: 10.1002/cpt.3095

2023年

受賞

  1. 唐　寧佳（Ningjia Tang）　日本薬学会第143年会
    学生優秀発表賞（ポスター発表の部）
    Population pharmacokinetics of tacrolimus in adult liver transplant patients in the first
    year
  2. 中岡 真悠子　第12回日本薬剤師レジデントフォーラム
    優秀ポスター賞
    抗菌薬の定数配置廃止に伴う緊急搬送対応とその評価

論文発表

  1. Kobayashi A, Ikemura K, Wakai E, Kondo M, Okuda M.
    Proton pump inhibitors ameliorate oxaliplatin-induced peripheral neuropathy: retrospective analysis of two real-world clinical databases.
    Anticancer Res. 43(12): 5613-5620 (2023) DOI: 10.21873/anticanres.16764.
  2. Kojima T, Kinoshita N, Kitamura H, Tanaka K, Tokunaga A, Nakagawa S, Abe T, Nakajima K.
    Effect of improvement measures in reducing interruptions in a Japanese hospital pharmacy using a synthetic approach based on resilience engineering and system thinking.
    BMC Health Serv Res. 23(1):331 (2023) DOI: 10.1186/s12913-023-09346-2.
  3. Kato T, Enokiya T, Morikawa Y, Okuda M, Imai H.
    Sequestration of antimicrobial agents in Xcoating and heparin-coated extracorporeal membrane oxygenation circuits: an in vitro study. 
    ASAIO J.  69(1):e23-e27 (2023) DOI: 10.1097/MAT.0000000000001842
  4. 新谷 拓也, 北村 温美, 兼児 敏浩, 武田 理宏 , 門脇 裕子, 奥田 真弘 , 中村 京太 , 中島 和江
    国立大学病院における免疫抑制・化学療法時の B 型肝炎再活性化予防対策に関する実態調査
    医療の質・安全学会誌、18(2): 148-157 (2023) 
  5. 上林 里絵, 池村 健治, 若井 恵里, 杉本 浩子, 平井 利典, 加藤 秀雄, 向原 里佳, 石倉 健, 今井 寛, 岩本 卓也
    集中治療室の専任薬剤師による注射処方発行前鑑査が薬物治療の適正化に及ぼす効果
    日本臨床救急医学会雑誌、26(1): 1-9 (2023) DOI: 10.11240/jsem.26.1
  6. 田墨 恵子,大村 望美, 上村 敬子, 原 伸輔, 水木 満佐央
    抗がん薬による曝露の実態と対策の検討 : 外来化学療法関連施設の環境調査より
    大阪大学看護学雑誌、29(1): 51-56 (2023) DOI: 10.18910/90031

  8. 総説

    山本智也 
    EGUIDEプロジェクトの挑戦
    ー精神科領域の国内診療ガイドラインの教育と普及の推進ー
    日本病院薬剤師会雑誌、59(2): 130-134 (2023)

2022年

受賞

  1. 小林 暉英　第43回日本臨床薬理学会学術総会
    優秀演題賞
    オキサリプラチン誘発末梢神経障害に対するプロトンポンプ阻害薬の予防効果に関する後方視的研究
  2. 竹村 美穂　第32回日本医療薬学会年会
    Young Investigator’s Award（学生）
    乳がん患者におけるカペシタビン誘発性手足症候群に対するプロトンポンプ阻害薬の予防効果
  3. 竹村 美穂　医療薬学フォーラム2022/第30回クリニカルファーマシーシンポジウム
    優秀ポスター賞
    慢性骨髄性白血病患者におけるダサチニブの治療効果に及ぼすフェブキソスタット併用の影響
  4. 孫 于婷 (YuTing Shun) The 21st Asian Conference on Clinical Pharmacy (ACCP2022)
    Best Poster (Student)
    Extracellular vesicle-derived miRNAs regulate osimertinib resistance in non-small cell lung cancer cell

論文発表

  1. Bai L, Tachibana K, Murata M, Inoue T, Mizuguchi H, Maeda S, Ikemura K, Okuda M, Kusakabe T, Kondoh M.
    A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine.
    Toxicol Lett. 370(1):1-6 (2022) DOI: 10.1016/j.toxlet.2022.09.005
  2. Takemura M, Ikemura K, Kondo M, Yamane F, Ueda M, Okuda M.
    Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis.
    J Pharm Health Care Sci. 8(1):21 (2022) DOI: 10.1186/s40780-022-00252-z.
  3. Wakai E, Ikemura K, Mizuno T, Takeuchi K, Tamaru S, Okuda M, Nishimura Y.
    Repositioning of lansoprazole as a protective agent against cisplatin-induced ototoxicity.
    Front Pharmacol. 13: 896760 (2022) DOI: 10.3389/fphar.2022.896760.
  4. Takemura M, Ikemura K, Yoshinami T, Toyozumi Y, Shintani T, Ueda M, Shimazu K, Okuda M.
    Proton pump inhibitors ameliorate capecitabine-induced hand-foot syndrome in patients with breast cancer: a retrospective study.
    Anticancer Res. 42(5): 2591-2598 (2022) DOI: 10.21873/anticanres.15737.
2021年

受賞

  1. 池村 健治　2021年度日本医療薬学会 奨励賞
    薬物動態学的アプローチを基盤としたがん薬物療法の副作用回避に向けたエビデンス構築
  2. 原 伸輔　第31回日本医療薬学会年会 優秀演題賞
    トリフルリジン／チピラシルの投与スケジュール変更における有効性と安全性の後⽅視的検討

    論文発表

    1. Yokoyama H, Shioyama W, Shintani T, Maeda S, Hirobe S, Maeda M, Sakata Y, Fujio Y.
      Vascular endothelial growth factor receptor inhibitors impair left ventricular diastolic functions.
      Int Heart J. 62(6): 1297-1304 (2021) DOI: 10.1536/ihj.21-307.
    2. Hirobe S, Susai R, Takeuchi H, Eguchi R, Ito S, Quan Y, Kamiyama F, Okada N.
      Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice.
      Int J Pharm. 601: 120563. (2021) DOI: 10.1016/j.ijpharm.2021.120563.
    4. Wakai E, Ikemura K, Kato C, Okuda M.
      Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension.
      PLoS ONE. 16(6): e0252944. (2021) DOI: 10.1371/journal.pone.0252944.
    5. Enokiya T, Nishikawa K, Hamada Y, Ikemura K, Sugimura Y, Okuda M.
      Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non-expressors early after living donor kidney transplantation: Effect of interleukin 6-induced suppression of the cytochrome P450 3A gene. 
      Basic Clin Pharmacol Toxicol. 128(3): 525-533 (2021) DOI: 10.1111/bcpt.13539.
    6. Okamoto A, Ikemura K, Mizutani E, Iwamoto T, Okuda M.
      Opioid therapy duration before naldemedine treatment is a significant independent risk of diarrhea: a retrospective cohort study.
      J Pharm Health Care Sci. 7(1): 3 (2021) DOI: 10.1186/s40780-020-00187-3.
    7. 村地康、細川祐岐、衣笠裕香、山本智也、奥田真弘
      抗がん剤の実地調製における曝露対策としてのネオシールド®の有用性評価
      日本病院薬剤師会雑誌、57(1): 63-69 (2021)
    8. 中村洋平、⼩倉裕司、松井浩子、前田真一郎、嶋津岳士
      持続血液濾過透析により改善したメトホルミンによる乳酸アシドーシスの1例.
      日本救急医学会雑誌、32: 86-91 (2021)
    2020年

    論文発表

    1. Ogami C, Tsuji Y, Muraki Y, Mizoguchi A, Okuda M, To H.
      Population pharmacokinetics and pharmacodynamics of teicoplanin and C-reactive protein in hospitalized patients with gram-positive infections.
      Clin Pharmacol Drug Dev. 9: 175-188 (2020) DOI: 10.1002/cpdd.684.
    2. Enokiya T, Hasegawa M, Muraki Y, Morikawa Y, Iwamoto T, Sudo A, Okuda M.
      Postoperative anaemia is a risk factor for major bleeding in thromboprophylaxis using fondaparinux sodium injection after total knee or hip arthroplasty.
      Biol Pharm Bull. 43: 266-271 (2020) DOI: 10.1248/bpb.b19-00447.
    3. Urano K, Ishibashi M, Matsumoto T, Ohishi K, Muraki Y, Iwamoto T, Kunimasa J, Okuda M.
      Impact of physician−pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study.
      J Pharm Health Care Sci. 6: 9 (2020) DOI: 10.1186/s40780-020-00165-9.
    4. Hiramatsu S, Ikemura K, Fujisawa Y, Iwamoto T, Okuda M.
      Concomitant lansoprazole ameliorates cisplatin-induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats.
      Biopharm Drug Dispos. 41(6): 239-247 (2020) DOI: 10.1002/bdd.2242.
    5. Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N, Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T, Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K, Inada K, Hashimoto R.
      Prescription patterns in patients with schizophrenia in Japan: first-quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project.
      Neuropsychopharmacol Rep. 40(3): 281-286 (2020) DOI: 10.1002/npr2.12122.
    6. Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A, Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y, Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T, Ito F, Imamura Y, Kido M, Nagasawa T, Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M, Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H, Hashimoto R.
      Unmet need for major depressive disorders-Findings from the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study.
      Psychiatry Clin Neurosci. 74(12): 667-669 (2020) DOI: 10.1111/pcn. 13143.
    7. Wakai E, Suzumura Y, Ikemura K, Mizuno T, Watanabe M, Takeuchi K, Nishimura Y.
      An Integrated in silico and in vivo approach to identify protective effects of palonosetron in cisplatin-induced nephrotoxicity.
      Pharmaceuticals. 13(12): 480 (2020) DOI: 10.3390/ph13120480.
    8. Mizutani H, Shiga C, Imai M, Ikemura K, Kitamura Y, Ohta K, Miyazawa D, Sakanashi M, Tahira T, Maeda T, Hiraku Y, Kawanishi S.
      Idarubicin, an anthracycline, induces oxidative DNA damage in the presence of copper (II).
      Anticancer Res. 40(10): 5399-5404 (2020) DOI: 10.21873/anticanres.14548.
    9. 若井恵里，池村健治，山崎大輔，石原幹也，岩本卓也，奥田真弘
      高速液体クロマトグラフィー(HPLC)を用いた簡便な血清中ミトタン濃度測定法の開発と臨床応用.
      TDM研究、37 (2): 77-83 (2020)
    10. 松井浩子，竹川良介，大西光雄，門脇裕子，嶋津岳士
      アシクロビル脳症の1例―腎機能障害下でのアシクロビル投与に関する考察―
      中毒研究、33(3): 216-218 (2020)
    2019年

    受賞

    1. 新谷 拓也　日本医療薬学会Postdoctral Award
      新規EGFR-TKI耐性獲得因子eIF3cの分子病理学的意義の解明とバイオマーカーとしての有用性の検討

    論文発表

    1. Kitayama K, Maeda S, Nakamura A, Katayama I, Wataya-Kaneda M. 
      Efficiency of sirolimus delivery to the skin is dependent on administration route and formulation. 
      J Dermatol Sci. 94: 350-353 (2019) DOI: 10.1016/j.jdermsci.2019.05.002.
    2. Nakagami H, Sugimoto K, Ishikawa T, Koshizaka M, Fujimoto T, Kiyohara E, Hayashi M, Nakagawa Y, Ando H, Terabe Y, Takami Y, Yamamoto K, Takeya Y, Takemoto M, Ebihara T, Nakamura A, Nishikawa M, Xiang Jing Yao, Hanaoka H, Yokote K, Rakugi H. 
      Investigator-initiated clinical study of a functional peptide, SR-0379, for limb ulcers of patients with Werner syndrome as a pilot study. 
      Geriatr Gerontol Int. 19(11): 1118-1123 (2019) DOI: 10.1111/ggi.13782.
    3. Ju N, Shimamura M, Hayashi H, Ikeda Y, Yoshida S, Nakamura A, Morishita R, Rakugi H, Nakagami H. 
      Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimodinduced psoriasis. 
      Sci Rep. 9(1): 15434 (2019) DOI: 10.1038/s41598-019-51681-0.
    4. Kokado R, Hagiya H, Morii D, Okuno H, Yamamoto N, Hamaguchi S, Yoshida H, Miwa Y. Tomono K. 
      Broad-spectrum antibiotic prescriptions are discontinued unevenly throughout the week. 
      J Hosp Infect. 101(4): 471-474 (2019) DOI: 10.1016/j.jhin.2018.11.004.
    5. Kokado R, Hagiya H, Koyama T, Matsui E, Okuno H, Morii D, Hamaguchi S, Yoshida H, Miwa Y, Tomono K. 
      Antibiotic-associated adverse drug events at a Japanese academic hospital. 
      J Infect Chemother. 25(5): 392-395 (2019) DOI: 10.1016/j.jiac.2018.11.002.
    6. Hagiya H, Kokado R, Okuno H, Tomono K. 
      Daptomycin-associated myopathy induced by concomitant administration of mirabegron. 
      Infection. 47(2): 331-332 (2019) DOI: 10.1007/s15010-018-1252-z.
    7. Morii D, Kokado R, Tomono K. 
      Hospital-by-hospital carbapenem use in Japan: a nationwide ecological study. 
      J Hosp Infect. 102(1):101-107 (2019) DOI: 10.1016/j.jhin.2018.11.009.
    8. Hagiya H, Kokado R, Ueda A, Okuno H, Morii D, Hamaguchi S, Yamamoto N, Yoshida H, Tomono K. 
      Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-centered Study. 
      Intern Med. 58(18): 2621-2625 (2019) DOI: 10.2169/internalmedicine.2603-18.
    9. Ikemura K, Hiramatsu S, Shinogi Y, Nakatani Y, Tawara I, Iwamoto T, Katayama N, Okuda M. 
      Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein. 
      Sci Rep. 9(1): 20359 (2019) DOI: 10.1038/s41598-019-56900-2.
    10. Matsuura H, Ujiie K, Duyen TTM, Izutsu K, Fujiyama K, Maeda S, Harada K, Hirata K. 
      Development of a Paper-Based Luminescence Bioassay for Therapeutic Monitoring of Aminoglycosides: a Proof-of-Concept Study. 
      Applied Biochemistry and Biotechnology. 189(3): 798-809 (2019) DOI: 10.1007/s12010-019-03048-4.
    11. Sasano M, Ohno M, Fukuda Y, Nonen S, Hirobe S, Maeda S, Miwa Y, Yokoyama J, Nakayama H, Miyagawa S, Sawa Y, Fujio Y, Maeda M. 
      Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients. 
      Eur J Clin Pharmacol. 75(7): 901-911 (2019) DOI: 10.1007/s00228-019-02656-7.
    12. 浦嶋庸子、岩本瑞樹、池田賢二、米田勇太、井上麻衣、松本数博、山崎肇、西川満則、廣谷芳彦 
      院内製剤フェノールグリセリン注射剤の安定性評価 
      日本病院薬剤師会雑誌、55(10): 1191-1194 (2019)
    ページ上部へ